Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001437749-13-011104
Filing Date
2013-08-19
Accepted
2013-08-19 17:25:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D pdli20130819_sc13d.htm SC 13D 105549
  Complete submission text file 0001437749-13-011104.txt   107321
Mailing Address 13859 PROGRESS BLVD. SUITE 100 ALACHUA FL 32615
Business Address 13859 PROGRESS BLVD. SUITE 100 ALACHUA FL 32615 (386) 462-6817
AxoGen, Inc. (Subject) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-38985 | Film No.: 131049086
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filed by) CIK: 0000882104 (see all company filings)

EIN.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2836 Biological Products, (No Diagnostic Substances)